Affiliation:
1. Department of Family and Community Medicine Saint Louis University School of Medicine St. Louis Missouri USA
2. Harry S. Truman Veterans Administration Medical Center Columbia Missouri USA
3. The Advanced HEAlth Data (AHEAD) Research Institute Saint Louis University School of Medicine St. Louis Missouri USA
4. School of Medicine, Department of Internal Medicine, Division of Geriatric Medicine, Saint Louis University School of Medicine Saint Louis University St. Louis Missouri USA
5. Department of Psychiatry and Behavioral Neuroscience, School of Medicine Saint Louis University St. Louis Missouri USA
Abstract
AbstractBackgroundPrescribing benzodiazepines to older patients is controversial. Anxiety disorders and benzodiazepines have been associated with dementia, but literature is inconsistent. It is unknown if anxiety treated with a benzodiazepine, compared to anxiety disorder alone is associated with dementia risk.MethodsA retrospective cohort study (n = 72,496) was conducted using electronic health data from 2014 to 2021. Entropy balancing controlled for bias by indication and other confounding factors. Participants: Eligible patients were ≥65 years old, had clinic encounters before and after index date and were free of dementia for 2 years prior to index date. Of the 72,496 eligible patients, 85.6% were White and 59.9% were female. Mean age was 74.1 (SD ± 7.1) years. Exposure: Anxiety disorder was a composite of generalized anxiety disorder, anxiety not otherwise specified, panic disorder, and social phobia. Sustained benzodiazepine use was defined as at least two separate prescription orders in any 6‐month period. Main outcome and measures: ICD‐9 or ICD‐10 dementia diagnoses.ResultsSix percent of eligible patients had an anxiety diagnosis and 3.6% received sustained benzodiazepine prescriptions. There were 6640 (9.2%) incident dementia events. After controlling for confounders, both sustained benzodiazepine use (HR 1.28, 95% CI: 1.11–1.47) and a diagnosis of anxiety (HR 1.19, 95% CI: 1.06–1.33) were associated with incident dementia in patients aged 65–75. Anxiety disorder with sustained benzodiazepine, compared to anxiety disorder alone, was not associated with incident dementia (HR 1.18, 95% CI: 0.92–1.51) after controlling for confounding. Results were not significant when limiting the sample to those ≥75 years of age.ConclusionsBenzodiazepines and anxiety disorders are associated with increased risk for dementia. In patients with anxiety disorders, benzodiazepines were not associated with additional dementia risk. Further research is warranted to determine if benzodiazepines are associated with a reduced or increased risk for dementia compared to other anxiolytic medications in patients with anxiety disorders.
Subject
Geriatrics and Gerontology
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献